San Diego, CA, United States of America

Leslie Ann Greene

USPTO Granted Patents = 75 

 

 

Average Co-Inventor Count = 6.9

ph-index = 9

Forward Citations = 495(Granted Patents)


Inventors with similar research interests:


Location History:

  • San Deigo, CA (US) (2017)
  • San Diego, CA (US) (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-NRP2 Antibodies
Histidyl-tRNA Synthetase
Aminoacyl tRNA Synthetases
Polypeptide Structural Motifs
Therapeutic Compositions
Diagnostic Compositions
Cell Signaling Activity
Protein Fragments
Inflammation Modulation
Cysteinyl-tRNA Synthetase
Threonyl-tRNA Synthetases
Glycyl-tRNA Synthetases
75 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Leslie Ann Greene in Biotechnology

Introduction

Leslie Ann Greene, based in San Diego, California, is a prominent inventor celebrated for his significant contributions to biotechnology. With a remarkable portfolio of 74 patents, Greene's innovations aim to advance therapeutic solutions for various diseases, particularly those linked to neuropilin-2 (NRP2) and related biological activities.

Latest Patents

Among Leslie Ann Greene's most recent patents is a groundbreaking invention involving therapeutic compositions that comprise anti-NRP2 antibodies. This invention provides affinity matured and humanized antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 (NRP2) polypeptides. These antibodies play a critical role in modulating binding interactions between NRP2 and its ligands, which subsequently influences NRP2-mediated downstream signaling events. This innovation presents potential therapeutic applications for treating diseases associated with NRP2.

Another noteworthy patent involves compositions and methods comprising histidyl-tRNA synthetase splice variants that exhibit non-canonical biological activities. Greene's research in this area has led to isolated polynucleotides and polypeptides with unique properties, paving the way for new therapeutic methods and compositions.

Career Highlights

Leslie Ann Greene has had an impactful career, working with leading companies in the biotechnology sector. He has notably contributed to Atyr Pharma, Inc. and Pangu Biopharma Limited, where he has been instrumental in driving research and innovation. His focus on diseases related to NRP2 has positioned him as a key figure in advancing therapeutic development in this area.

Collaborations

Throughout his career, Greene has collaborated with esteemed colleagues, including Fei Hong and Jeffry Dean Watkins. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the development of innovative therapies stemming from Greene's research.

Conclusion

Leslie Ann Greene exemplifies the spirit of innovation within the biotechnology field. His extensive patent portfolio reflects his dedication to advancing medical science and offering novel solutions for treating diseases. As he continues to innovate, the contributions of Leslie Ann Greene are likely to have a lasting impact on the field of therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…